Goldman Sachs’s KALA BIO KALA Stock Holding History
Bought
Maintained
Sold
Other funds holding KALA
VF
ACM
GCP
VCM
Goldman Sachs's KALA Position: Q1 2026 in Review
Goldman Sachs opened a new position in KALA BIO (KALA) in Q1 2026: 281 shares worth $2.43K. The stake represents ﹤0.01% of the portfolio and ranks #6418 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in KALA as recently as Q3 2022.
Goldman Sachs first reported a position in KALA in Q4 2017 and has held it in 21 quarters since. The position peaked at $3.82M in Q1 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.
- Goldman Sachs held 281 shares of KALA BIO worth $2.43K as of Q1 2026.
- KALA BIO was a new Goldman Sachs position in Q1 2026.
- KALA BIO made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6418 holding.
- Goldman Sachs first reported a position in KALA BIO in Q4 2017 and has held it in 21 quarters since.
- Goldman Sachs's KALA BIO position peaked at $3.82M in Q1 2020.
- 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.